IL22 and neoplasm: In bacteria-induced colon cancer, IL-17 and IL-22-producing colonic ILCs are involved in driving pro-tumor responses; specifically, IL-22 sustains inflammation during cancer by STAT3 phosphorylation in epithelial cells inducing proliferation [68].